320 results on '"Januszewski, Andrzej S."'
Search Results
2. An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetes
3. Review and comparison of retinal vessel calibre and geometry software and their application to diabetes, cardiovascular disease, and dementia
4. Association of circulating fibroblast growth factor 21 levels with all-cause and cardiovascular mortality: The multi-ethnic study of atherosclerosis
5. Assessing Insulin Sensitivity in People with Type 1 Diabetes Without Euglycemic-Hyperinsulinemic Clamps
6. Lipoprotein Glycation in Diabetes Mellitus
7. Mitochondrial DNA copy number in adults with and without Type 1 diabetes
8. Correction to: Assessing Insulin Sensitivity in People with Type 1 Diabetes Without Euglycemic-Hyperinsulinemic Clamps
9. Assessing Insulin Sensitivity in People with Type 1 Diabetes Without Euglycemic-Hyperinsulinemic Clamps
10. High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)
11. Telomeres do not always shorten over time in individuals with type 1 diabetes
12. Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy
13. Correction to: Assessing Insulin Sensitivity in People with Type 1 Diabetes Without Euglycemic-Hyperinsulinemic Clamps
14. Machine learning workflows identify a microRNA signature of insulin transcription in human tissues
15. Diabetes, metabolic disease, and telomere length
16. Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate.
17. Management of Diabetes Mellitus
18. Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study
19. Estimated insulin sensitivity in Type 1 diabetes adults using clinical and research biomarkers
20. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial
21. Interactive calculator to estimate insulin sensitivity in type 1 diabetes
22. Increased Diabetes Complications in a Mouse Model of Oxidative Stress Due to ‘Mismatched’ Mitochondrial DNA
23. Is it time to screen health literacy in diabetes clinical practice?
24. Insulin micro-secretion in Type 1 diabetes and related microRNA profiles
25. Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
26. Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes
27. Increased intracellular miR-142 in adults with Type 1 diabetes
28. FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease
29. Not enough known about fenofibrate’s kidney effects in people with Type 2 diabetes
30. The Pathobiology of Diabetes Mellitus
31. Management of Diabetes Mellitus
32. Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial
33. Optimized plasma sample preparation and LC‐MS analysis to support large‐scale proteomic analysis of clinical trial specimens: Application to the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial
34. Muscle grip strength predicts incident type 2 diabetes: Population-based cohort study
35. Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
36. Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes
37. Lipoprotein Glycation in Diabetes Mellitus
38. Fish oil and multivitamin supplementation reduces oxidative stress but not inflammation in healthy older adults: A randomised controlled trial
39. No relationship between socioeconomic status, education level and development and progression of diabetic retinopathy in type 2 diabetes: a FIELD trial substudy.
40. Corrigendum to “Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy” [Diab. Res. Clin. Pract. 186 (2022) 109835]
41. Independent euglycaemic hyperinsulinaemic clamp studies validate clinically applicable formulae to estimate insulin sensitivity in people with type 1 diabetes
42. Corrigendum to “Independent euglycaemic hyperinsulinaemic clamp studies validate clinically applicable formulae to estimate insulin sensitivity in people with type 1 diabetes” [Diabetes Metabol Syndr Clin Res Rev 17(1) (2023) 102691]
43. Telomeres in clinical diabetes research – Moving towards precision medicine in diabetes care?
44. Supplemental Material - Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial
45. Optimal frequency of retinopathy screening in adolescents with type 1 diabetes - Markov modelling approach based on 30-years of data
46. 403-P: Reduced Mitochondrial DNA Copy Number in Type 1 Diabetes and Nephropathy and Correlates Thereof
47. The association between total phthalate concentration and non-communicable diseases and chronic inflammation in South Australian urban dwelling men
48. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study
49. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study
50. The Pathobiology of Diabetes Mellitus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.